                         SEQUENCE LISTING

<110>  INSERM
 
<120>  ANTI-NEUROTENSIN LONG FRAGMENT ANTIBODIES AND USES THEREOF

<130>  BIO14016 FORGEZ / MC

<160>  10    

<170>  PatentIn version 3.3

<210>  1
<211>  116
<212>  PRT
<213>  Artificial

<220>
<223>  VH Sequence

<400>  1

Gln Ile Gln Leu Val Gln Ser Gly Pro Glu Leu Lys Lys Pro Gly Glu 
1               5                   10                  15      


Thr Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asn Tyr 
            20                  25                  30          


Gly Met Asn Trp Val Lys Gln Ala Pro Gly Lys Gly Leu Lys Trp Met 
        35                  40                  45              


Gly Trp Ile Thr Thr Asn Thr Gly Glu Pro Thr Tyr Ala Glu Glu Phe 
    50                  55                  60                  


Lys Gly Arg Phe Ala Phe Ser Leu Glu Thr Ser Ala Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Ile Asn Asn Leu Lys Asn Glu Asp Thr Ala Thr Tyr Phe Cys 
                85                  90                  95      


Ala Arg Arg Ala Phe Ala Met Asp Tyr Trp Gly Gln Gly Thr Ser Val 
            100                 105                 110         


Thr Val Ser Ser 
        115     


<210>  2
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  H-CDR1

<400>  2

Gly Tyr Thr Phe Thr Asn Tyr Gly Met Asn 
1               5                   10  


<210>  3
<211>  17
<212>  PRT
<213>  Artificial

<220>
<223>  H-CDR2

<400>  3

Trp Ile Thr Thr Asn Thr Gly Glu Pro Thr Tyr Ala Glu Glu Phe Lys 
1               5                   10                  15      


Gly 
    


<210>  4
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  H-CDR3

<400>  4

Arg Ala Phe Ala Met Asp Tyr 
1               5           


<210>  5
<211>  112
<212>  PRT
<213>  Artificial

<220>
<223>  VL sequence

<400>  5

Asp Ile Val Met Thr Gln Ala Ala Pro Ser Val Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Ser Val Ser Ile Ser Cys Arg Ser Ser Lys Ser Leu Leu His Ser 
            20                  25                  30          


Asn Gly Asn Thr Tyr Leu Tyr Trp Phe Leu Gln Arg Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Leu Leu Ile Tyr Arg Met Ser Asn Leu Ala Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Ala Phe Thr Leu Arg Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln His 
                85                  90                  95      


Leu Glu Tyr Pro Tyr Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110         


<210>  6
<211>  16
<212>  PRT
<213>  Artificial

<220>
<223>  L-CDR1

<400>  6

Arg Ser Ser Lys Ser Leu Leu His Ser Asn Gly Asn Thr Tyr Leu Tyr 
1               5                   10                  15      


<210>  7
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  L-CDR2

<400>  7

Arg Met Ser Asn Leu Ala Ser 
1               5           


<210>  8
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  L-CDR3

<400>  8

Met Gln His Leu Glu Tyr Pro Tyr Thr 
1               5                   


<210>  9
<211>  170
<212>  PRT
<213>  Homo sapiens

<400>  9

Met Met Ala Gly Met Lys Ile Gln Leu Val Cys Met Leu Leu Leu Ala 
1               5                   10                  15      


Phe Ser Ser Trp Ser Leu Cys Ser Asp Ser Glu Glu Glu Met Lys Ala 
            20                  25                  30          


Leu Glu Ala Asp Phe Leu Thr Asn Met His Thr Ser Lys Ile Ser Lys 
        35                  40                  45              


Ala His Val Pro Ser Trp Lys Met Thr Leu Leu Asn Val Cys Ser Leu 
    50                  55                  60                  


Val Asn Asn Leu Asn Ser Pro Ala Glu Glu Thr Gly Glu Val His Glu 
65                  70                  75                  80  


Glu Glu Leu Val Ala Arg Arg Lys Leu Pro Thr Ala Leu Asp Gly Phe 
                85                  90                  95      


Ser Leu Glu Ala Met Leu Thr Ile Tyr Gln Leu His Lys Ile Cys His 
            100                 105                 110         


Ser Arg Ala Phe Gln His Trp Glu Leu Ile Gln Glu Asp Ile Leu Asp 
        115                 120                 125             


Thr Gly Asn Asp Lys Asn Gly Lys Glu Glu Val Ile Lys Arg Lys Ile 
    130                 135                 140                 


Pro Tyr Ile Leu Lys Arg Gln Leu Tyr Glu Asn Lys Pro Arg Arg Pro 
145                 150                 155                 160 


Tyr Ile Leu Lys Arg Asp Ser Tyr Tyr Tyr 
                165                 170 


<210>  10
<211>  16
<212>  PRT
<213>  Artificial

<220>
<223>  antigen peptide

<400>  10

Cys Gln Glu Asp Ile Leu Asp Thr Gly Asn Asp Lys Asn Gly Lys Glu 
1               5                   10                  15      


